According to Day One Biopharmaceuticals's latest financial reports the company has $0.36 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.36 B | 7.03% |
2022-12-31 | $0.34 B | 20.39% |
2021-12-31 | $0.28 B | 550.18% |
2020-12-31 | $43.72 M | 59.99% |
2019-12-31 | $27.33 M |